Your shopping cart is currently empty

AMX5160 (36) is an orally active BTK inhibitor with an IC50 value of 0.98 nM for BTKC481S. It is utilized in research pertaining to multiple sclerosis and other autoimmune diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | AMX5160 (36) is an orally active BTK inhibitor with an IC50 value of 0.98 nM for BTKC481S. It is utilized in research pertaining to multiple sclerosis and other autoimmune diseases. |
| In vitro | AMX5160 exhibits an IC50 value of 93.2 nM in TMD8 cells and 85.85 nM in Ba/F3-BTK-C481S cells. |
| In vivo | AMX5160 (36; NIH/3T3-FL-BTK-C481S xenograft BALB/c nude mouse model; 10, 25, 75 mg/kg; oral; twice daily) significantly inhibits tumor growth in a dose-dependent manner. Tumor growth inhibition rates (TGI) are 58%, 63%, and 82% at doses of 10, 25, and 75 mg/kg, respectively. AMX5160 (36) is well-tolerated in mice. |
| Molecular Weight | 502.99 |
| Formula | C28H27ClN4O3 |
| Cas No. | 2639293-95-9 |
| Smiles | C(=O)(C=1C2=C(N[C@H]3CC[C@@H](NC(C)=O)CC3)C=CN=C2NC1)C4=C(Cl)C=C(OC5=CC=CC=C5)C=C4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.